ReviewDiabetes research and clinical practice2021
Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa.
Review in Diabetes research and clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 57 citations in OpenAlex.
- The impact of diabetes and obesity on the severity and mortality of SARS-CoV-2 infection.Journal of diabetes and metabolic disorders · 2025Review
- Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania.Global health action · 2024Article
- Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Applications of digital health approaches for cardiometabolic diseases prevention and management in the Western Pacific region.The Lancet regional health. Western Pacific · 2024Review
- COVID-19 Vaccine Acceptance and Hesitancy among Healthcare Workers in Lusaka, Zambia; Findings and Implications for the Future.Vaccines · 2023Article
- The impact of the covid-19 pandemic on diabetes care: the perspective of healthcare providers across Europe.Primary care diabetes · 2023Article
- Nurse-led telehealth intervention effectiveness on reducing hypertension: a systematic review.BMC nursing · 2023Article
- Observational
- Review
- Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study.Obesity medicine · 2022Article
- Experience with Obese Patients Followed via Telemedicine in a Latin American Tertiary Care Medical Center.International journal of environmental research and public health · 2022Article
- Implementation of a Teleneurology Clinic in Zambia during the COVID-19 Pandemic.Annals of neurology · 2022Observational
- Telehealth Secure Solution to Provide Childhood Obesity Monitoring.Sensors (Basel, Switzerland) · 2022Article
- Short report: Weight management of children and adolescents with obesity during the COVID-19 pandemic in Germany.PloS one · 2022Article
- The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism.Expert opinion on drug safety · 2021Review
- The role of airborne particles and environmental considerations in the transmission of SARS-CoV-2.Geoscience frontiers · 2021Review
- Incretin-based therapies in 2021 - Current status and perspectives for the future.Metabolism: clinical and experimental · 2021Article
- Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus.World journal of diabetes · 2021Review
- Article
- Anxiety and Depression Prevalence and Risk Factors Among Patients With Cardiovascular Diseases in Post-COVID-19 China.Frontiers in public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 10 institutions in 10 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has had a major effect on healthcare during 2020. Current evidence suggests that, while individuals with diabetes and obesity are no more prone to SARS-CoV-2 infection than those without, the risk of hospitalisation if someone has diabetes or obesity and then contracts COVID-19 is three times higher - and 4.5 times higher if they have diabetes and obesity. We assembled a panel of experts from South and East Europe, the Middle East, and Africa to discuss the challenges to management of diabetes and obesity during and post the COVID-19 pandemic. The experience and learnings of this panel cover a heterogeneous patient population, wide range of clinical settings, healthcare organisations, disease management strategies, and social factors. We discuss the importance of timely and effective disease management via telemedicine, providing reassurance and guidance for patients unable or unwilling to visit healthcare settings at this time. We address the use of novel therapies and their role in managing diabetes and obesity during the pandemic, as well as the importance of controlling hypoglycaemia and preventing cardiovascular complications, particularly in vulnerable people. Finally, we consider post-COVID-19 management of diabetes and obesity, and how these learnings and experiences should impact upon future clinical guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.